CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to stop psychosis before it starts using CBD
Disease control Not yet recruitingThis large, international study is testing whether a two-year course of cannabidiol (CBD) can reduce early warning signs of psychosis and prevent its full onset in young people identified as being at high clinical risk. Nearly 600 participants, aged 12-35, will be randomly assign…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Mindfulness training aims to stop psychosis before it starts
Prevention Not yet recruitingThis study is testing whether group mindfulness therapy can help prevent young adults at high risk for psychosis from developing full psychosis. It will compare mindfulness sessions plus usual care against usual care alone in 270 participants aged 18-30. The main goal is to see i…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Phone app aims to lift mood for those with schizophrenia
Symptom relief Not yet recruitingThis study is testing a brief mobile phone app designed to help improve mood by addressing unhelpful thinking patterns. It will involve 100 people who either have schizophrenia or are at high risk for developing psychosis. The main goal is to see if the app is helpful and easy to…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Scientists scan brains to predict psychosis before it strikes
Knowledge-focused Not yet recruitingThis study aims to understand how psychosis develops by looking at brain chemistry in young adults who are at high risk for the condition. Researchers will use special brain scans (PET and MRI) to measure dopamine, a brain chemical linked to psychosis, in 115 participants aged 18…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE1 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC